T2 Biosystems, Inc. Quarterly Marketable Securities, Current in USD from Q2 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
T2 Biosystems, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2020 to Q4 2023.
  • T2 Biosystems, Inc. Marketable Securities, Current for the quarter ending December 31, 2023 was $0.000.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 $0 Dec 31, 2023 10-K 2024-04-01
Q4 2022 $0 -$10M -100% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $0 -$20M -100% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 -$20.1M -100% Jun 30, 2022 10-Q 2022-08-16
Q1 2022 $9.99M -$12.6M -55.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $10M -$15.4M -60.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $20M -$1.95M -8.86% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $20.1M +$10.8M +117% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $22.6M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $25.4M Dec 31, 2020 10-K 2022-03-23
Q3 2020 $22M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $9.25M Jun 30, 2020 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.